{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Rethinking Pharma Commercial Targeting with AI - with Philip Poulidis of ODAIA","description":"Commercial life\u2011sciences teams are facing a widening gap between strong brand strategy and fragmented real\u2011world execution, driven by misaligned workflows, static targeting, and an inability to act at the speed patients move through their therapeutic journeys. In this episode, Philip Poulidis, CEO and Co-founder of ODAIA, unpacks how AI can close that gap by connecting brand intent to real\u2011time execution, enabling teams to prioritize the right HCPs, orchestrate engagement, and measure impact through outcomes rather than activity metrics. He highlights the practical shifts required to get there \u2014 from cross\u2011functional adoption and workflow\u2011embedded insights to attribution modeling, efficiency gains, and focused pilots that prove value quickly. This episode is sponsored by ODAIA. Learn how brands work with Emerj and other Emerj Media options at emerj.com\/partner. Want to share your AI adoption story with executive peers? Click  emerj.com\/expert for more information and to be a potential future guest on the \u2018AI in Business\u2019 podcast! ","author_name":"The AI in Business Podcast","author_url":"http:\/\/emerj.com","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/40309585\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/3a80a9\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/199208400"}